Why the study?
Recent evidence implicating structural genes and atrial fibrosis challenges the traditional view of AF as purely an electrical disease, prompting an evaluation of its complex genetic basis and the role of common and rare variants.
This review highlights the evolving understanding of atrial fibrillation from a purely electrical disease to a complex polygenetic condition involving structural atrial cardiomyopathies.
Answers are grounded in this paper and cite their sources.
AF genetic associations do not yet alter clinical practice; leaves open targeted therapies for atrial cardiomyopathies.
Atrial fibrillation (AF) is the most common type of arrhythmia. Epidemiological studies have documented a substantial genetic component. More than 160 genes have been associated with AF during the last decades. Some of these were discovered by classical linkage studies while the majority relies on functional studies or genome-wide association studies. In this review, we will evaluate the genetic basis of AF and the role of both common and rare genetic variants in AF. Rare variants in multiple ion-channel genes as well as gap junction and transcription factor genes have been associated with AF. More recently, a growing body of evidence has implicated structural genes with AF. An increased burden of atrial fibrosis in AF patients compared with non-AF patients has also been reported. These findings challenge our traditional understanding of AF being an electrical disease. We will focus on several quantitative landmark papers, which are transforming our understanding of AF by implicating atrial cardiomyopathies in the pathogenesis. This new AF research field may enable better diagnostics and treatment in the future.
No takes yet. Share an insight, caveat, or question.
Andersen et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: